Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuqin Zeng

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Journal of Global Health|February 20, 2025
The treatment responses among different inhalation therapies for GOLD group E patients with chronic obstructive pulmonary diseaseQing Song, Ling Lin, Tao Li, et al.
Pulmonology|May 11, 2026
Clinical features and longitudinal assessment in outcomes of chronic obstructive pulmonary disease with biomass smoke exposure history: A prospective study of the RealDTC cohortLing Lin, Jing Li, Tao Li, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 1, 2023
Prediction of Hospitalization and Mortality in Patients with Chronic Obstructive Pulmonary Disease with the New Global Initiative for Chronic Obstructive Lung Disease 2023 Group Classification: A Prospective Cohort and a Retrospective AnalysisWei Cheng, Aiyuan Zhou, Yuqin Zeng, et al.
Journal of Global Health|February 20, 2026
The risk factors of future exacerbations and treatment responses among different inhalation therapies of patients with preserved ratio impaired spirometryJun Cao, Tian Sun, Huan Yang, et al.
Therapeutic Advances in Respiratory Disease|November 29, 2023
The future exacerbation and mortality of different inhalation therapies among patients with chronic obstructive pulmonary disease in various GOLD groups: a focus on the GOLD 2017 and GOLD 2023 reportsQing Song, Wei Cheng, Cong Liu, et al.
Journal of Global Health|November 30, 2023
Clinical characteristics and risk of all-cause mortality in low education patients with chronic obstructive pulmonary disease in the Chinese populationQing Song, Cong Liu, Wei Cheng, et al.
Journal of Global Health|October 10, 2024
Impact of exacerbation history on future risk and treatment outcomes in chronic obstructive pulmonary disease patients: A prospective cohort study based on Global Initiative for Chronic Obstructive Lung Disease (GOLD) A and B classificationsLing Lin, Qing Song, Wei Cheng, et al.
Annals of Medicine|March 29, 2023
The effects of different inhalation therapies on less symptomatic chronic obstructive pulmonary disease patients in a Chinese population: a real-world studyQing Song, Ling Lin, Aiyuan Zhou, et al.
Frontiers in Pharmacology|October 8, 2021
Real-World Effectiveness of Inhalation Therapy Among Patients With Symptomatic COPD in China: A Multicenter Prospective StudyWei Cheng, Jiaxi Duan, Aiyuan Zhou, et al.
Annals of Medicine|January 17, 2024
The clinical characteristics and outcomes of different inhaled therapies in chronic obstructive pulmonary disease patients with frequent coughXueshan Li, Qing Song, Wei Cheng, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal of Global Health|February 20, 2025
The treatment responses among different inhalation therapies for GOLD group E patients with chronic obstructive pulmonary diseaseQing Song, Ling Lin, Tao Li, et al.
Pulmonology|May 11, 2026
Clinical features and longitudinal assessment in outcomes of chronic obstructive pulmonary disease with biomass smoke exposure history: A prospective study of the RealDTC cohortLing Lin, Jing Li, Tao Li, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 1, 2023
Prediction of Hospitalization and Mortality in Patients with Chronic Obstructive Pulmonary Disease with the New Global Initiative for Chronic Obstructive Lung Disease 2023 Group Classification: A Prospective Cohort and a Retrospective AnalysisWei Cheng, Aiyuan Zhou, Yuqin Zeng, et al.
Journal of Global Health|February 20, 2026
The risk factors of future exacerbations and treatment responses among different inhalation therapies of patients with preserved ratio impaired spirometryJun Cao, Tian Sun, Huan Yang, et al.
Therapeutic Advances in Respiratory Disease|November 29, 2023
The future exacerbation and mortality of different inhalation therapies among patients with chronic obstructive pulmonary disease in various GOLD groups: a focus on the GOLD 2017 and GOLD 2023 reportsQing Song, Wei Cheng, Cong Liu, et al.
Journal of Global Health|November 30, 2023
Clinical characteristics and risk of all-cause mortality in low education patients with chronic obstructive pulmonary disease in the Chinese populationQing Song, Cong Liu, Wei Cheng, et al.
Journal of Global Health|October 10, 2024
Impact of exacerbation history on future risk and treatment outcomes in chronic obstructive pulmonary disease patients: A prospective cohort study based on Global Initiative for Chronic Obstructive Lung Disease (GOLD) A and B classificationsLing Lin, Qing Song, Wei Cheng, et al.
Annals of Medicine|March 29, 2023
The effects of different inhalation therapies on less symptomatic chronic obstructive pulmonary disease patients in a Chinese population: a real-world studyQing Song, Ling Lin, Aiyuan Zhou, et al.
Frontiers in Pharmacology|October 8, 2021
Real-World Effectiveness of Inhalation Therapy Among Patients With Symptomatic COPD in China: A Multicenter Prospective StudyWei Cheng, Jiaxi Duan, Aiyuan Zhou, et al.
Annals of Medicine|January 17, 2024
The clinical characteristics and outcomes of different inhaled therapies in chronic obstructive pulmonary disease patients with frequent coughXueshan Li, Qing Song, Wei Cheng, et al.
Pageof 6